Pillay Y

What will it take for an injectable ARV to change the face of the HIV epidemic in high-prevalence countries? Considerations regarding drug costs and operations.
Meyer-Rath G, Jamieson L, Pillay Y

Journal of the International AIDS Society

(2023)

https://doi.org/10.1002/jia2.26106
Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa
Mehta UC, van Schalkwyk C, Naidoo P, Ramkissoon A, Mhlongo O, Maharaj NR, Naidoo N, Fieggen K, Urban MF, Krog S, Welte A, Dheda M, Pillay Y, Moran NF

Southern African Journal of HIV Medicine

(2019)

https://doi.org/10.4102/sajhivmed.v20i1.971
Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
Wallengren K, Scano F, Nunn P, Margot B, Buthelezi SSS, Williams BG, Pym A, Samuel EY, Mirzayev F, Nkhoma W, Mvusi L, Pillay Y

Emerging Infectious Diseases

(2011)

https://doi.org/10.3201/eid1710.100952